IQVIA Holdings Inc. (IQV) advances clinical research and data capabilities to drive growth

IQVIA Holdings Inc. (NYSE:IQV) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 3, analysts at RBC Capital initiated coverage of IQVIA Holdings Inc. (NYSE:IQV) with an Outperform ...
Benzinga.com

Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst

On Monday, Janux Therapeutics, Inc. (NASDAQ:JANX) revealed updated interim clinical data for its JANX007 clinical program. “These clinical data show substantial activity with JANX007 in 5L metastatic ...

X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention

Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained ...
Fierce Biotech

PepGen hit with partial clinical hold, analyst blames 'understaffed FDA'

The FDA has put a partial clinical hold on PepGen’s phase 2 mus | The FDA has put a partial clinical hold on PepGen’s phase 2 muscle wasting trial after reviewing preclinical data, continuing the stop ...

Monte Rosa Therapeutics earnings on deck amid revenue decline

Monte Rosa Therapeutics Inc. reports fourth-quarter and full-year 2025 results Thursday, closing out a year marked by promising clinical data but facing investors’ questions about revenue ...